APUS

Profile

Full Name

Apimeds Pharmaceuticals US, Inc

Ticker Symbol

APUS

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

Indexes

Not included

Website

http://www.apimedsus.com

Employees

2

Key Details

Price

$1.64(-8.89%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.11(-62.22% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.64
    APUS price is $1.64

    30-Day Relative Volume

    0.45
    APUS 30-day relative volume is 0.45

    Price Performance

    Price Most recent change

    -8.89%
    APUS price was down -8.89% on May 28, 2025

    Price YTD change

    -
    APUS price ytd change is unknown

    Price 1-year change

    -
    APUS price 1-year change is unknown

    Price 3-year change

    -
    APUS price 3-year change is unknown

    Price Range

    Price All-time high

    $4.00
    APUS price is currently -59.00% below its historical high of $4.00

    Price 3-year low

    $0.00
    APUS price is currently >+9900.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $20.82M
    APUS market capitalization is $20.82 million

    Market cap 3-year change

    -
    APUS market capitalization 3-year change is unknown

    Market cap All-time high

    $27.93M
    APUS market capitalization is currently -25.45% below its historical high of $27.93 million

    Market cap sector rank

    26.33%
    APUS market capitalization is higher than 26.33% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    APUS shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    APUS shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -2.53
    APUS beta is -2.53

    200-day SMA

    $1.68
    APUS price is currently -2.57% below its 200-day simple moving average

    50-day SMA

    $1.68
    APUS price is currently -2.57% below its 50-day simple moving average

    RSI

    68.12
    APUS 14-day relative strength index is 68.12

    Volume

    0.45
    APUS 30-day relative volume is 0.45

    ATR

    $0.20
    APUS average true range is $0.20

    10-day Historical Volatility

    77.40%
    APUS 10-day historical volatility is 77.40%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    APUS annual revenue value is unknown

    Revenue Analysts estimate

    -
    APUS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    APUS annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    APUS annual revenue is unknown

    EPS

    EPS

    -$0.11
    APUS annual earnings per share is -$0.11

    EPS Analysts estimate

    -
    APUS annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -62.22%
    APUS annual earnings per share is down -62.22% year-on-year

    EPS Sector rank

    79.14%
    APUS annual earnings per share is higher than 79.14% of companies in Healthcare sector

    Profit

    Gross profit

    -
    APUS annual gross profit value is unknown

    Gross margin

    -
    APUS annual gross profit margin value is unknown

    Operating profit

    -$1.28M
    APUS annual operating income is -$1.28 million

    Operating margin

    -
    APUS annual operating profit margin value is unknown

    Net income

    -$1.39M
    APUS annual net profit is -$1.39 million

    Net margin

    -
    APUS annual net profit margin value is unknown

    Expenses

    Total expenses

    $1.28M
    APUS annual total expenses is $1.28 million

    Operating expenses

    $1.28M
    APUS annual total operating expenses is $1.28 million

    Cost of goods sold

    -
    APUS annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $1.28M
    APUS annual SGA is $1.28 million

    Depreciation and amortization

    -
    APUS annual depreciation & amortization value is unknown

    Interest expense

    $117.70K
    APUS annual interest expense is $117.70 thousand

    Income tax

    -
    APUS annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$1.27M
    APUS annual earnings before interest & taxes is -$1.27 million

    EBITDA

    -$1.27M
    APUS annual EBITDA is -$1.27 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $13.10K
    APUS annual total assets is $13.10 thousand

    Non current assets

    $0.00
    APUS annual long term assets is $0.00

    Current assets

    $13.10K
    APUS annual total current assets is $13.10 thousand

    Cash and cash equivalents

    $3500.00
    APUS annual cash & cash equivalents is $3500.00

    Accounts receivable

    -
    APUS annual accounts receivable value is unknown

    Inventory

    -
    APUS annual inventory value is unknown

    Liabilities

    Total liabilities

    $1.37M
    APUS annual total liabilities is $1.37 million

    Long term liabilities

    $346.80K
    APUS annual total long term liabilities is $346.80 thousand

    Current liabilities

    $1.02M
    APUS annual total current liabilities is $1.02 million

    Accounts payable

    -
    APUS annual accounts payable value is unknown

    Debt

    Total debt

    $596.80K
    APUS annual total debt is $596.80 thousand

    Total debt 1-year change

    +123.6%
    APUS annual total debt is up +123.6% year-on-year

    Long term debt

    $346.80K
    APUS annual long term debt is $346.80 thousand

    Short term debt

    $250.00K
    APUS annual short term debt is $250.00 thousand

    Equity & Capital

    Shareholders equity

    -$1.36M
    APUS annual stockholders equity is -$1.36 million

    Book value

    -$1.36M
    APUS annual book value is -$1.36 million

    Retained earnings

    -$4.39M
    APUS annual retained earnings is -$4.39 million

    Working capital

    -$1.01M
    APUS annual working capital is -$1.01 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$733.50K
    APUS annual cash flow from operations is -$733.50 thousand

    Cash from operations 1-year change

    -16.84%
    APUS annual cash flow from operations is down -16.84% year-on-year

    Cash from investing

    $0.00
    APUS annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    APUS {parameterFullLabel} has remained unchanged year-on-year

    Cash from financing

    $326.50K
    APUS annual cash flow from financing activities is $326.50 thousand

    Cash from financing 1-year change

    -68.37%
    APUS annual cash flow from financing activities is down -68.37% year-on-year

    CAPEX

    CAPEX

    -
    APUS annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    APUS annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$733.50K
    APUS annual free cash flow is -$733.50 thousand

    Free cash flow 1-year change

    -16.84%
    APUS annual free cash flow is down -16.84% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    APUS annual gross profit margin value is unknown

    Operating margin

    -
    APUS annual operating profit margin value is unknown

    Net margin

    -
    APUS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -10.61K%
    APUS annual return on assets is -10.61 thousand%

    ROE

    102.35%
    APUS annual return on equity is 102.35%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    APUS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    APUS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    APUS price to book ratio value is unknown

    PB ratio Sector rank

    -
    APUS price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    APUS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    APUS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    APUS enterprise value value is unknown

    Enterprise value Sector rank

    -
    APUS enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    APUS EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    APUS EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.01
    APUS annual current ratio is 0.01

    Quick ratio

    -
    APUS annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.44
    APUS annual debt to equity ratio is -0.44

    Interest coverage ratio

    -10.81
    APUS annual interest coverage ratio is -10.81

    Risk & Stability

    Piotroski F-Score

    -
    APUS piotroski f-score value is unknown

    Altman Z-Score

    -
    APUS altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with APUS included

    US stocks
    Stocks below SMA 200
    Healthcare sector
    All stocks
    Ex Dividend dates calendar
    Small cap stocks
    NYSE Companies
    Stocks with low beta
    Specialty & Generic Drug Manufacturers industry
    • What is the ticker symbol for Apimeds Pharmaceuticals US?
    • Does Apimeds Pharmaceuticals US pay dividends?
    • What sector is Apimeds Pharmaceuticals US in?
    • What industry is Apimeds Pharmaceuticals US in?
    • What country is Apimeds Pharmaceuticals US based in?
    • Is Apimeds Pharmaceuticals US in the S&P 500?
    • Is Apimeds Pharmaceuticals US in the NASDAQ 100?
    • Is Apimeds Pharmaceuticals US in the Dow Jones?
    • When does Apimeds Pharmaceuticals US report earnings?

    What is the ticker symbol for Apimeds Pharmaceuticals US?

    The ticker symbol for Apimeds Pharmaceuticals US is NYSE:APUS

    Does Apimeds Pharmaceuticals US pay dividends?

    No, Apimeds Pharmaceuticals US does not pay dividends

    What sector is Apimeds Pharmaceuticals US in?

    Apimeds Pharmaceuticals US is in the Healthcare sector

    What industry is Apimeds Pharmaceuticals US in?

    Apimeds Pharmaceuticals US is in the Drug Manufacturers - Specialty & Generic industry

    What country is Apimeds Pharmaceuticals US based in?

    Apimeds Pharmaceuticals US is headquartered in United States

    Is Apimeds Pharmaceuticals US in the S&P 500?

    No, Apimeds Pharmaceuticals US is not included in the S&P 500 index

    Is Apimeds Pharmaceuticals US in the NASDAQ 100?

    No, Apimeds Pharmaceuticals US is not included in the NASDAQ 100 index

    Is Apimeds Pharmaceuticals US in the Dow Jones?

    No, Apimeds Pharmaceuticals US is not included in the Dow Jones index

    When does Apimeds Pharmaceuticals US report earnings?

    The date for Apimeds Pharmaceuticals US's next earnings report has not been announced yet
    On this page